SCHEMBL8907781

SCHEMBL8907781

CC1(C)CCC(C)(C)c2cc(COc3ccc(C(=O)O)c(O)c3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.53
RXRA P19793 5/20 0.52
RXRB P28702 3/20 0.52
RXRG P48443 3/20 0.52
PPARG P37231 3/20 0.52
MAOA P21397 6/20 0.48
CYP26A1 O43174 2/20 0.48
CYP26B1 Q9NR63 2/20 0.48
CYP3A4 P08684 1/20 0.48
RARA P10276 1/20 0.46
RARB P10826 1/20 0.46
RARG P13631 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8907419 0.89 PPARG (0.55) MAOBRXRARXRBRXRGPPARG
SCHEMBL9272893 0.89 MAOB (0.49) MAOBRXRARXRBRXRGPPARG
SCHEMBL9194990 0.87 RARG (0.52) RXRARXRBRXRGPPARGCYP26A1
SCHEMBL9275250 0.86 RXRB (0.53) MAOBRXRARXRBRXRGPPARG
SCHEMBL9274012 0.85 KDM4E (0.53) MAOBRXRARXRBRXRGPPARG
SCHEMBL9699620 0.85 MAOB (0.45) MAOBRXRARXRBRXRGPPARG
SCHEMBL8839066 0.84 RXRA (0.52) RXRARXRBRXRGPPARGCYP26A1
SCHEMBL8676840 0.83 RXRB (0.71) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL5184246 0.82 CYP26A1 (0.74) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL8674842 0.81 RXRA (0.68) RXRARXRBRXRGPPARGCYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5654331-A SKIN AND RESPIRATORY SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS; ANTIALLERGENS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1997-08-05 US disclosed
US-5476860-A Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (CIRD GALDERMA) (FR) 1995-12-19 US disclosed
EP-0514264-B1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics CIRD GALDERMA (FR) 1995-11-15 EP disclosed
WO-1995001966-A1 IODINATED OLIGOMERIC COMPOUNDS AND DIAGNOSTIC COMPOSITIONS CONTAINING THE SAME BRACCO S.P.A. (IT) 1995-01-19 WO disclosed
WO-1992020643-A1 NOVEL BI-AROMATIC COMPOUNDS DERIVED FROM A SALICILIC PATTERN, METHOD OF PREPARATION AND USE IN HUMAN AND VETERINARY MEDECINE AND IN COSMETICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-11-26 WO disclosed
EP-0514264-A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1992-11-19 EP disclosed
WO-1992006948-A1 BI-AROMATIC COMPOUNDS AND THEIR USE IN HUMAN AND VETERINARY MEDECINE AND IN COSMETIC PREPARATIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-04-30 WO disclosed